Brief: Shionogi: Signed Sub-Licensing Agreement With JEIL Pharmaceutical For Development And Sale Of Drug That Treats Infections Caused By Antimicrobial Resistance28/07/2022 02:51
Last trade - 00:00Last trade - 00:00Last trade - 00:00